Orthofix Medical Total Assets Growth & History (OFIX)
Orthofix Medical's total assets was $850.6M for fiscal 2025.
View full Orthofix Medical company overviewOrthofix Medical annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $850.6M | −$42.6M | −4.77% |
| 2024 | 2024-12-31 | $893.3M | −$32.0M | −3.46% |
| 2023 | 2023-12-31 | $925.3M | $466.7M | +101.76% |
| 2022 | 2022-12-31 | $458.6M | −$18.0M | −3.78% |
| 2021 | 2021-12-31 | $476.6M | −$49.2M | −9.36% |
| 2020 | 2020-12-31 | $525.9M | $30.2M | +6.10% |
| 2019 | 2019-12-31 | $495.6M | $29.0M | +6.21% |
| 2018 | 2018-12-31 | $466.6M | $61.3M | +15.12% |
| 2017 | 2017-12-31 | $405.4M | $33.3M | +8.94% |
| 2016 | 2016-12-31 | $372.1M | −$28.1M | −7.03% |
| 2015 | 2015-12-31 | $400.2M | $7.3M | +1.85% |
| 2014 | 2014-12-31 | $393.0M | −$19.0M | −4.62% |
| 2013 | 2013-12-31 | $412.0M | −$52.6M | −11.32% |
| 2012 | 2012-12-31 | $464.5M | −$220.8M | −32.22% |
| 2011 | 2011-12-31 | $685.4M | $81.4M | +13.48% |
| 2010 | 2010-12-31 | $604.0M | — | — |
Orthofix Medical quarterly total assets
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $873.0M | $35.9M | +4.28% |
| Q1 2026 | 2026-03-31 | $886.6M | $63.5M | +7.71% |
| Q4 2025 | 2025-12-31 | $850.6M | −$42.6M | −4.77% |
| Q3 2025 | 2025-09-30 | $832.6M | −$35.3M | −4.06% |
| Q2 2025 | 2025-06-30 | $837.2M | −$44.8M | −5.08% |
| Q1 2025 | 2025-03-31 | $823.1M | −$82.9M | −9.15% |
| Q4 2024 | 2024-12-31 | $893.3M | −$32.0M | −3.46% |
| Q3 2024 | 2024-09-30 | $867.9M | −$37.8M | −4.17% |
| Q2 2024 | 2024-06-30 | $882.0M | −$19.3M | −2.14% |
| Q1 2024 | 2024-03-31 | $906.0M | −$11.1M | −1.21% |
| Q4 2023 | 2023-12-31 | $925.3M | $466.7M | +101.76% |
| Q3 2023 | 2023-09-30 | $905.7M | $456.0M | +101.41% |
| Q2 2023 | 2023-06-30 | $901.3M | $439.6M | +95.23% |
| Q1 2023 | 2023-03-31 | $917.1M | $455.1M | +98.52% |
| Q4 2022 | 2022-12-31 | $458.6M | −$18.0M | −3.78% |
| Q3 2022 | 2022-09-30 | $449.7M | −$50.7M | −10.14% |
| Q2 2022 | 2022-06-30 | $461.7M | −$40.4M | −8.04% |
| Q1 2022 | 2022-03-31 | $462.0M | −$51.9M | −10.10% |
| Q4 2021 | 2021-12-31 | $476.6M | −$49.2M | −9.36% |
| Q3 2021 | 2021-09-30 | $500.4M | −$16.7M | −3.24% |
| Q2 2021 | 2021-06-30 | $502.0M | −$93.7M | −15.73% |
| Q1 2021 | 2021-03-31 | $513.9M | $20.4M | +4.13% |
| Q4 2020 | 2020-12-31 | $525.9M | $30.2M | +6.10% |
| Q3 2020 | 2020-09-30 | $517.1M | $41.5M | +8.73% |
| Q2 2020 | 2020-06-30 | $595.7M | $106.9M | +21.87% |
| Q1 2020 | 2020-03-31 | $493.5M | $14.2M | +2.96% |
| Q4 2019 | 2019-12-31 | $495.6M | $29.0M | +6.21% |
| Q3 2019 | 2019-09-30 | $475.6M | $25.4M | +5.65% |
| Q2 2019 | 2019-06-30 | $488.8M | $47.0M | +10.65% |
| Q1 2019 | 2019-03-31 | $479.3M | $70.3M | +17.19% |
| Q4 2018 | 2018-12-31 | $466.6M | $61.3M | +15.12% |
| Q3 2018 | 2018-09-30 | $450.2M | $63.9M | +16.53% |
| Q2 2018 | 2018-06-30 | $441.8M | $74.1M | +20.15% |
| Q1 2018 | 2018-03-31 | $409.0M | $54.3M | +15.30% |
| Q4 2017 | 2017-12-31 | $405.4M | $33.3M | +8.94% |
| Q3 2017 | 2017-09-30 | $386.3M | $10.2M | +2.73% |
| Q2 2017 | 2017-06-30 | $367.7M | $2.9M | +0.81% |
| Q1 2017 | 2017-03-31 | $354.7M | −$8.0M | −2.21% |
| Q4 2016 | 2016-12-31 | $372.1M | −$28.1M | −7.03% |
| Q3 2016 | 2016-09-30 | $376.1M | −$26.4M | −6.56% |
| Q2 2016 | 2016-06-30 | $364.7M | −$24.4M | −6.27% |
| Q1 2016 | 2016-03-31 | $362.8M | −$23.9M | −6.19% |
| Q4 2015 | 2015-12-31 | $400.2M | $7.3M | +1.85% |
| Q3 2015 | 2015-09-30 | $402.4M | −$8.6M | −2.09% |
| Q2 2015 | 2015-06-30 | $389.2M | −$44.8M | −10.33% |
| Q1 2015 | 2015-03-31 | $386.7M | −$17.3M | −4.27% |
| Q4 2014 | 2014-12-31 | $393.0M | −$19.0M | −4.62% |
| Q3 2014 | 2014-09-30 | $411.0M | −$19.0M | −4.42% |
| Q2 2014 | 2014-06-30 | $434.0M | −$25.5M | −5.54% |
| Q1 2014 | 2014-03-31 | $404.0M | −$71.8M | −15.09% |
| Q4 2013 | 2013-12-31 | $412.0M | −$52.6M | −11.32% |
| Q3 2013 | 2013-09-30 | $430.1M | −$135.0M | −23.89% |
| Q2 2013 | 2013-06-30 | $459.4M | −$93.9M | −16.96% |
| Q1 2013 | 2013-03-31 | $475.8M | −$231.8M | −32.76% |
| Q4 2012 | 2012-12-31 | $464.5M | −$220.8M | −32.22% |
| Q3 2012 | 2012-09-30 | $565.1M | −$91.0M | −13.87% |
| Q2 2012 | 2012-06-30 | $553.3M | −$93.7M | −14.48% |
| Q1 2012 | 2012-03-31 | $707.6M | — | — |
| Q4 2011 | 2011-12-31 | $685.4M | $81.4M | +13.48% |
| Q3 2011 | 2011-09-30 | $656.1M | — | — |
| Q2 2011 | 2011-06-30 | $647.0M | — | — |
| Q4 2010 | 2010-12-31 | $604.0M | — | — |
Orthofix Medical total assets trends
Over the last five fiscal years, Orthofix Medical's total assets increased from $525.9M to $850.6M, a change of $324.8M. The latest reported quarter, Q2 2026, shows $873.0M.
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Orthofix Medical source filings ↗